Shows
Progress, Potential, and Possibilities Podcast / ShowDr. Parag Mallick, PhD - Co-Founder, Nautilus Biotechnology - Unlocking The Complexity Of The Proteome For A New Era Of Scientific DiscoverySend us a textDr. Parag Mallick, Ph.D. is an Associate Professor at Stanford University ( https://profiles.stanford.edu/parag-mallick ) and Co-Founder of Nautilus Biotechnology ( https://www.nautilus.bio/ ), a development stage life sciences company, engaged in creating a platform technology for quantifying and unlocking the complexity of the proteome for a new era of scientific discovery. Originally trained as an engineer and biochemist, Dr. Mallick’s research spans proteomics, computational and experimental systems biology, cancer biology and nanotechnology. Dr. Mallick received his B.S. in Computer Science from Washington University in St...2024-08-2154 min
Is It Just Speculation?Professor Ruedi Aebersold - Biologist, 2020 Marcel Benoist Prize Winner - Ep. 19Ruedi Aebersold is a Swiss and Canadian scientist. He trained at the Biocenter, University of Basel, Switzerland and completed his education at Caltech. He was on the faculties of the University of British Columbia in Vancouver and the University of Washington in Seattle and co-founded, with Lee Hood and Alan Aderem, the Institute for Systems Biology in Seattle, a world first. He has co-founded several companies and holds several public service appointments. Ruedi was awarded an honorary doctorate of the University of Lund, Sweden and the work of the group was recognized with numerous prizes and awards including the Biemann...2022-02-2053 min
Investor Town Hall ShowPressure Biosciences, Inc. (OTCQB: PBIO)Revenue Continues to IncreasePressure Biosciences, Inc. (OTCQB: PBIO) CEO Ric Schumacher was on Investor Town Hall Show discussing the latest company developments.
Operational & Technical Highlights: FY2017
A significant software upgrade for our flagship Barocycler 2320EXTREME has brought our next-generation PCT-based instrument to GMP and GLP compliance, which in turn should open many new doors in the biopharmaceutical manufacturing and drug discovery & development areas of the very large life sciences field.
The acquisition of all assets of BaroFold Corporation combines BaroFold's patented high-pressure protein refolding technology (PreEMT) with PBI's leadership in high-pressure instrumentation and worldwide market access, which will allow PBI entry into the...2018-04-2813 min
Fakultät für Chemie und Pharmazie - Digitale Hochschulschriften der LMU - Teil 05/06Dissection of the topology, structure and function of the INO80 chromatin remodelerEukaryotic genomes are organized into highly condensed chromatin. This packaging obviously impedes essential DNA mediated processes. ATP-dependent chromatin remodelers are therefore required to establish a dynamic chromatin environment. The chromatin remodeler INO80 is involved in various fundamental nuclear processes such as DNA repair, DNA replication and transcription. INO80 is thought to contribute to these processes by controlling genome wide levels of the histone variant H2A.Z. The INO80 chromatin remodeler is a macro-molecular complex composed of >15 subunits and a molecular mass of ~1.3 MDa. INO80 is found in human, fly and yeast. INO80 contains core subunits, which are conserved across...2013-11-2200 min
Futures in Biotech (Video)It's Time To Proteo Me - How mass spectrometry has become one of the most important technologies in our move toward personalized medicine.
How mass spectrometry has become one of the most important technologies in our move toward personalized medicine.
Hosts: Marc Pelletier and Vincent Racaniello, Ph.D
Guest: Ruedi Aebersold
Sponsored by: Synergy 1.
We invite you to read, add to, and amend our show notes.
Comments and suggestions on Futures in Biotech.
Also thanks to Phil Pelletier and Will Hall for the great themes.
Thanks to CacheFly for providing the bandwidth for this netcast.
2011-02-251h 08
Futures in Biotech (Audio)It's Time To Proteo Me - How mass spectrometry has become one of the most important technologies in our move toward personalized medicine.
How mass spectrometry has become one of the most important technologies in our move toward personalized medicine.
Hosts: Marc Pelletier and Vincent Racaniello, Ph.D
Guest: Ruedi Aebersold
Sponsored by: Synergy 1.
Thanks to Phil Pelletier and Will Hall for the great themes.
Thanks to CacheFly for providing the bandwidth for this netcast.
2011-02-251h 08